Alpha Teknova Inc TKNO

Morningstar Rating
$5.42 +0.10 (1.88%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TKNO is trading at a LOCK|ZChS< premium.
Price
$5.42
Fair Value
LOCK|@KfQ@%
Uncertainty
LOCK|#S
1-Star Price
LOCK|H$WQ&wc
5-Star Price
LOCK|VW$cbM$
Economic Moat
LOCK|!>^
Capital Allocation

Trading Information

Previous Close Price
$5.32
Day Range
$5.235.64
52-Week Range
$1.916.68
Bid/Ask
$2.75 / $6.35
Shares Outstanding
53.61M
Market Cap
$290.59M
Volume/Avg
73,042 / 164,820

Key Statistics

Price/Earnings (Normalized)
Price/Sales
6.94
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield

Company Profile

Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
158

Valuation

Metric
TKNO
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
6.94
Price/Cash Flow
Price/Earnings
TKNO

Financial Strength

Metric
TKNO
Quick Ratio
3.40
Current Ratio
4.59
Interest Coverage
−20.77
Quick Ratio
TKNO

Profitability

Metric
TKNO
Return on Assets (Normalized)
−13.62%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−13.82%
Return on Assets
TKNO

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|w@&M<!vLOCK|$^ld$68B
Haleon PLC ADR
HLN
LOCK|XJM!d%LOCK|>>N$44B
Teva Pharmaceutical Industries Ltd ADR
TEVA
LOCK|$qVQ^?CLOCK|w&vB$38B
Zoetis Inc Class A
ZTS
LOCK|>#D!nMPLOCK|lw&$32B
Viatris Inc
VTRS
LOCK|@NLDvMLOCK|%f&$20B
Elanco Animal Health Inc
ELAN
LOCK|WKKLOCK|k>$13B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|n#d>q@>LOCK|R<$10B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|Mxr^^!LOCK|pm$8B
Prestige Consumer Healthcare Inc
PBH
LOCK|>r@nyl$LOCK|gy^PP$2B
Perrigo Co PLC
PRGO
LOCK|NnPtR&tLOCK|^^?$1B

Sponsor Center